Skip to main content
SpringerLink
Log in

The Role of Drug Treatment in Children with Strabismus and Amblyopia

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Strabismus, or misalignment of the eyes, is a common ophthalmic problem in childhood, affecting 2 to 5% of the preschool population. Amblyopia is an important cause of visual morbidity frequently associated with strabismus, and both conditions should be treated simultaneously. Pharmacological means for treating strabismus and amblyopia can be divided into 3 categories: paralytic agents (botulinum toxin) used directly on the extraocular muscles to affect eye movements; autonomic agents (atropine, miotics) used topically to manipulate the refractive status of the eye and thereby affect alignment, focus and amblyopia; and centrally acting agents, including levodopa and citicoline, which affect the central visual system abnormalities in amblyopia.

Botulinum toxin, the paralytic agent that causes the clinical symptoms of botulism poisoning, can be injected in minute quantities to achieve controlled paralysis of the extraocular muscles. Although the role of botulinum toxin is established in adults with paralytic strabismus, its usefulness in the treatment of comitant childhood strabismus (primary esotropia and exotropia) is not universally accepted. Botulinum injections tend to be more effective with smaller degrees of strabismus, in patients with good binocular fusion, and in managing overcorrections or undercorrections after traditional muscle surgery. Inadvertent ptosis and paralysis of adjacent muscles, unpredictable responses and technical constraints of the injections limit its use in children.

Miotic therapy, by altering the refractive state of the treated eye, offers an alternative to optical correction with bifocals in treating esotropia due to excessive accommodative convergence. It is also effective in treating residual esotropia following surgery. The ease of use of glasses restricts the wide application of miotics in these common strabismus syndromes.

Atropine, an anticholinergic agent, paralyses the ability of the eye to focus or accommodate. In amblyopia therapy, atropine is used to blur vision in the nonamblyopic eye and offers a useful alternative to traditional occlusion therapy with patching, especially in older children who are not compliant with patching.

The neurotransmitter precursor levodopa and the related compound citicoline have been demonstrated to improve vision in amblyopic eyes. The therapeutic role of these centrally acting agents in the clinical management of amblyopia remains unproven.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol Vis Sci 1973; 12: 924–7

    CAS  Google Scholar 

  2. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991 Apr 25; 324(17): 1186–94

    Article  CAS  PubMed  Google Scholar 

  3. Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol 1991; 36: 28–46

    Article  CAS  PubMed  Google Scholar 

  4. Kao I, Drachman DB, Price DL. Botulinum toxin: mechanism of presynaptic blockade. Science 1976; 193: 1256–8

    Article  CAS  PubMed  Google Scholar 

  5. Rosenbaum AL. The current use of botulinum toxin therapy in strabismus [editorial]. Arch Ophthalmol 1996; 114: 213–4

    Article  CAS  PubMed  Google Scholar 

  6. Tyler HR. Pathology of neuromuscular apparatus in botulism. Arch Pathol 1963; 76: 55–9

    CAS  PubMed  Google Scholar 

  7. Scott AB. Change of eye muscle sarcomeres according to eye position. J Pediatr Ophthalmol Strabismus 1994; 31: 85–8

    CAS  PubMed  Google Scholar 

  8. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophth Soc 1981; 79: 734–70

    CAS  Google Scholar 

  9. Scott AB, Magoon EH, McNeer KW, et al. Botulinum treatment of childhood strabismus. Ophthalmology 1990; 97: 1434–8

    CAS  PubMed  Google Scholar 

  10. Elston J. Is botulinum toxin helpful in squint management? [editorial]. Br J Ophthalmol 1998; 82: 105–6

    Article  CAS  PubMed  Google Scholar 

  11. Ing MR. Botulinum alignment for congenital esotropia. Ophthalmology 1993; 100: 318–22

    CAS  PubMed  Google Scholar 

  12. Lingua RW. Sequelae of botulinum toxin injection. Am J Ophthalmol 1985; 100: 305–7

    CAS  PubMed  Google Scholar 

  13. Burns CL, Gammon JA, Gemmill MC. Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm. Ophthalmology 1986; 93: 1621–7

    CAS  PubMed  Google Scholar 

  14. Tejedor J, Rodriguez JM. Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum injection. Br J Ophthalmol 1988; 82: 110–4

    Article  Google Scholar 

  15. Carruthers JDA. Botulinum toxin A for strabismus therapy. In: Albert DA, editor. Ophthalmic surgery: principles and techniques. Maiden (MA): Blackwell Science, 1999: 948–69

    Google Scholar 

  16. Scott AB. Botulinum toxin treatment of strabismus: focal points. Clin Modules Ophthalmol 1989; 7: 1–11

    Google Scholar 

  17. Magoon EH, Scott AB. Botulinum toxin chemodenervation in infants and children: an alternative to incisional strabismus surgery. J Pediatr 1987; 110: 719–22

    Article  CAS  PubMed  Google Scholar 

  18. Rosenbaum AL, Kushner BJ, Kirschen D. Vertical rectus muscle transposition and botulinum toxin (Oculinum) to medial rectus for abducens palsy. Arch Ophthalmol 1989; 107: 820–3

    Article  CAS  PubMed  Google Scholar 

  19. Fitzsimons R, Lee JP, Elston JS. Treatment of sixth nerve palsy in adults with combined botulinum toxin chemodenervation and surgery. Ophthalmology 1988; 95: 1535–42

    CAS  PubMed  Google Scholar 

  20. Metz HS, Dickey CF. Treatment of unilateral acute sixth-nerve palsy with botulinum toxin. Am J Ophthalmol 1991 Oct; 112: 381–4

    CAS  PubMed  Google Scholar 

  21. Mets HS, Mazow ML. Botulinum toxin: treatment of acute VI and III nerve palsies. Graefe’s Arch Clin Exp Ophthalmol 1988; 226: 141–4

    Article  Google Scholar 

  22. Lee JP. Modern management of VI nerve palsy. Aust NZJ Ophthalmol 1990; 20: 41–6

    Article  Google Scholar 

  23. von Noorden GK. Binocular vision and ocular motility: theory and management of strabismus. 5th ed. St Louis (MO): Mosby, 1996: 308

    Google Scholar 

  24. Biglan AW, Burnstine RA, Rogers GL, et al. Management of strabismus with botulinum Atoxin. Ophthalmology 1989; 96: 935–43

    CAS  PubMed  Google Scholar 

  25. McNeer KW, Spencer RF, Tucker MG. Observations on bilateral simultaneous botulinum toxin injection in infantile esotropia. J Pediatr Ophthalmol Strabismus 1994; 31: 214–9

    CAS  PubMed  Google Scholar 

  26. McNeer KW, Tucker MG, Spencer RF. Botulinum toxin management of essential infantile esotropia in children. Arch Ophthalmol 1997; 115: 1411–8

    Article  CAS  PubMed  Google Scholar 

  27. Helveston EM, Ellis FD, Schott J. Surgical treatment of congenital esotropia. Am J Ophthalmol 1983; 96: 219–28

    Google Scholar 

  28. Magoon EH. Chemodenervation in strabismic children: a 2- to 5-year follow-up study compared with shorter follow-up. Ophthalmology 1989; 96: 931–4

    CAS  PubMed  Google Scholar 

  29. Kushner BJ. Botulinum toxin management of essential infantile esotropia in children [editorial]. Arch Ophthalmol 1997; 115: 1458–9

    Article  CAS  PubMed  Google Scholar 

  30. Spencer RF, Tucker MG, Choi RY, et al. Botulinum toxin management of childhood intermittent exotropia. Ophthalmology 1997; 104: 1762–7

    CAS  PubMed  Google Scholar 

  31. McNeer KW. An investigation of the clinical use of botulinum toxin as a postoperative adjustment procedure in the therapy of strabismus. J Pediatr Ophthalmol Strabismus 1990; 27(1): 3–9

    CAS  PubMed  Google Scholar 

  32. Carruthers J. The treatment of congenital nystagmus with Botox. J Pediatr Ophthalmol Strabismus 1995 Sep-Oct; 32(5): 306–8

    CAS  PubMed  Google Scholar 

  33. Ruben ST, Lee JP, O’Neil D, et al. The use of botulinum toxin for treatment of acquired nystagmus and oscillopsia. Ophthalmo 1994; 101(4): 783–7

    CAS  Google Scholar 

  34. Goldstein JH. The role of miotics in strabismus. Surv Ophthalmol 1968; 13: 31–46

    CAS  PubMed  Google Scholar 

  35. Abraham SV. The use of miotics in the treatment of convergent strabismus and anisometropia: a preliminary report. Am J Ophthalmol 1949; 32: 233–40

    CAS  PubMed  Google Scholar 

  36. von Noorden GK. Binocular vision and ocular motility: theory and management of strabismus. 5th ed. St Louis (MO): Mosby, 1996: 508–9

    Google Scholar 

  37. Abraham S. Present status of miotic therapy in nonparalytic convergent strabismus. Am J Ophthalmol 1961; 51: 1249–55

    CAS  PubMed  Google Scholar 

  38. Wheeler MC, Moore S. DFP in the handling of esotropia. Am Orthopt J 1964; 14: 178–88

    CAS  PubMed  Google Scholar 

  39. Bedrossian EH, Krewson WE. Iso fluorphate versus glasses in evaluating the accommodative element in esotropia. Arch Ophthalmol 1966; 76: 186–8

    Article  CAS  PubMed  Google Scholar 

  40. Ripps H, Chin NB, Siegel IM, et al. The effect of pupil size on accommodation, convergence, and the AC/A ratio. Invest Ophthalmol 1962 Feb; 1: 127–35

    CAS  PubMed  Google Scholar 

  41. Breinin GM, Chin NB, Ripps H. A rationale for therapy of accommodative strabismus. Am J Ophthalmol 1966; 61: 1030–7

    CAS  PubMed  Google Scholar 

  42. Knapp P. Use of miotics in esotropia. J Iowa State Med Soc 1956; 46: 581–5

    CAS  PubMed  Google Scholar 

  43. Koskinen K. Experiments with the use of miotics in convergent strabismus. Acta Ophthalmol 1957; 35: 521–7

    CAS  Google Scholar 

  44. Stephenson RW. The use of miotics in the treatment of convergent squint. Trans Ophthalmol Soc UK 1959; 79: 15–24

    CAS  PubMed  Google Scholar 

  45. Ludwig IH, Parks MM, Jetson PP. Long-term results of bifocal therapy for accommodative esotropia. J Pediatr Ophthalmol Strabismus 1989; 26: 264–70

    CAS  PubMed  Google Scholar 

  46. von Noorden GK, Morris J, Edelman P. Efficacy of bifocals in the treatment of accommodative esotropia. Am J Ophthalmol 1978; 85: 830–4

    Google Scholar 

  47. Diorio PC. The role of miotics in the management of accommodative esotropia. Am Orthopt J 1977; 27: 96–9

    CAS  PubMed  Google Scholar 

  48. Hiatt RL. Medical management of accommodative esotropia. J Pediatr Ophthalmol Strabismus 1983 Sep-Oct; 20(5): 199–201

    CAS  PubMed  Google Scholar 

  49. Spierer A, Zeeli T. Postoperative miotics for patients with infantile esotropia. Ophthalmic Surg Lasers 1997 Dec; 28(12): 1002–5

    CAS  PubMed  Google Scholar 

  50. Knapp P, Capobianco NM. Use of miotics in esotropia. Am Orthopt J 1956; 6: 40

    PubMed  Google Scholar 

  51. Records RE. Side-reactions to anticholinesterase therapy for strabismus. Am Orthopt J 1967; 17: 44–6

    CAS  PubMed  Google Scholar 

  52. Kanski JJ. Miotics. Br J Ophthalmol 1968; 53: 963–4

    Google Scholar 

  53. von Noorden GK. Binocular vision and ocular motility: theory and management of strabismus. 5th ed. St Louis (MO): Mosby, 1996: 513–8

    Google Scholar 

  54. Simons K, Stei L, Sener EC, et al. Full-time atropine, intermittent atropine and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997; 104: 2143–55

    CAS  PubMed  Google Scholar 

  55. Simmons K. Preschool vision screening: rationale, methodology and outcome. Surv Ophthalmol 1996; 41: 3–30

    Article  Google Scholar 

  56. Woodruff G, Hiscox F, Thompson JR, et al. Factors affecting the outcome of children treated for amblyopia. Eye 1994; 8: 627–31

    Article  PubMed  Google Scholar 

  57. von Noorden GK, Milam JB. Penalization in the treatment of amblyopia. Am J Ophthalmol 1979; 88: 511–8

    Google Scholar 

  58. Frank JW, France TD. Penalization revisited: refractive penalization in the treatment of amblyopia. Am Orthopt J 1982; 32: 90–5

    Google Scholar 

  59. Foley-Nolan A, McCann A, O’Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol 1997; 81: 54–7

    Article  CAS  PubMed  Google Scholar 

  60. Sinelli-Mattheu J. Pharmacological treatment of amblyopia: atropine penalization. Am Orthopt J 1997; 48: 3–7

    Google Scholar 

  61. Swann AP, Hunter CD. A survey of amblyopia treated by atropine occlusion. Br Orthopt J 1974; 31: 65–9

    Google Scholar 

  62. Ron A, Nawratzki I. Penalization treatment of amblyopia: a follow-up study of two years in older children. J Pediatr Ophthalmol Strabismus 1982 May/Jun; 19(3): 137–9

    CAS  PubMed  Google Scholar 

  63. Repka MX, Ray JM. The efficacy of optical and pharmacological penalization. Ophthalmology 1993; 100: 769–75

    CAS  PubMed  Google Scholar 

  64. Simons K, Gotzler KC, Vitale S. Penalization versus part-time occlusion and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997; 104: 2156–60

    CAS  PubMed  Google Scholar 

  65. Noorden GK von. Amblyopia caused by unilateral atropinization. Ophthalmology 1981; 88: 131–3

    Google Scholar 

  66. North RV, Kelly ME. Atropine occlusion in the treatment of strabismic amblyopia and its effect upon the non-amblyopic eye. Ophthalmic Physiol Opt 1991; 11(2): 113–7

    Article  CAS  PubMed  Google Scholar 

  67. Bietti GB, Sorsonelli M. Azione dell’ O2 suifenomeni di soppressione in vivione binoculare degli strabici. Riv Med Aeronaut 1955; 18: 23

    CAS  PubMed  Google Scholar 

  68. Bietti GB. Sur la possibilite d’un traitement medicamenteux des phenomenes suppressifs en vision binoculaire dans le strabisme. Probl Actuels Ophthalmol 1957; 1: 391

    Google Scholar 

  69. Nagel A. Die Behandlung der Maaurosen und Amblyopien mit Strychnin. Klin Monatsbl Augenheild 1871; 9: 261

    Google Scholar 

  70. Barany EH, Hallden U. Phasic inhibition of the light reflex of the pupil during retinal rivalry. J Neurophysiol 1948; 11: 25

    CAS  PubMed  Google Scholar 

  71. von Noorden GK. Binocular vision and ocular motility: theory and management of strabismus. 5th ed. St Louis (MO): Mosby, 1996: 225

    Google Scholar 

  72. Leguire LE, Rogers GL, Bremer DL, et al. Levodopa and childhood amblyopia. J Pediatr Ophthalmol Strabismus 1992; 29: 290–8

    CAS  PubMed  Google Scholar 

  73. Gottlob I, Weghaupt H, Vass C, et al. Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials. Graefe’s Arch Clin Exp Ophthalmol 1989; 277: 421–7

    Article  Google Scholar 

  74. Gottlob I, Weghaupt H, Vass C. Effect of levodopa on the human luminance electroretinogram. Invest Ophthalmol Vis Sci 1990; 31: 1252–8

    CAS  PubMed  Google Scholar 

  75. Daw NW, Rader RK, Robertson TW, et al. Effects of 6-hydroxydopamine on visual deprivation in the kitten striate cortex. J Neurosci 1983; 3: 907–14

    CAS  PubMed  Google Scholar 

  76. Leguire LE, Walson PD, Rogers GL, et al. Levodopa/carbidopa treatment for amblyopia in older children. J Pediatr Ophthalmol Strabismus 1995; 32: 143–51

    CAS  PubMed  Google Scholar 

  77. Gottlob I, Stangler-Zuschrott E. Effect of levodopa on contrast sensitivity and scotomas in human amblyopia. Invest Ophthalmol Vis Sci 1990; 31: 776–80

    CAS  PubMed  Google Scholar 

  78. Leguire LE, Walson PD, Rogers GL, et al. Longitudinal study of levodopa/carbidopa for childhood amblyopia. J Pediatr Ophthalmol Strabismus 1993; 30: 354–60

    CAS  PubMed  Google Scholar 

  79. Leguire LE, Rogers GL, Bremer DL, et al. Levodopa/carbidopa for childhood amblyopia. Invest Ophthalmol Vis Sci 1993; 34: 3090–5

    CAS  PubMed  Google Scholar 

  80. Campos EC, Schiavi C, Benedetti P. Citocoline improves temporarily visual acuity of amblyopic patients outside the plastic period of the visual system. In: Lennerstand G, editor. Proceedings of the seventh International Strabismological Association; 1994 Jun 18–22; Vancouver. Boca Raton: CRC Press, 1995: 55

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, 2870 University Ave, Suite 206, Madison, Wisconsin, 53705, USA

    Klio I. Chatzistefanou & Monte D. Mills (Associate Professor of Ophthalmology, Director, Pediatric Ophthalmology and Strabismus)

Authors
  1. Klio I. Chatzistefanou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monte D. Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monte D. Mills.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatzistefanou, K.I., Mills, M.D. The Role of Drug Treatment in Children with Strabismus and Amblyopia. Pediatr-Drugs 2, 91–100 (2000). https://doi.org/10.2165/00148581-200002020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200002020-00002

Keywords

Search

Navigation